with management options that importantly alter clinical course. In this context, many efforts have been made to identify risk factors and improve the accuracy of patient selection for device therapy and prevention of SCD. Although the wellknown mathematical models and stated criteria could provide a solid basis for arrhythmic risk stratification, at present patient risk assessment is moving in the direction of a periodic multiparametric evaluation on an individual basis, which cannot prescind from CMR and genetic information.

The Arrhythmic Phenotype in Cardiomyopathy

Merlo, Marco;Grilli, Giulia;Cappelletto, Chiara;Porcari, Aldostefano;Ferro, Matteo Dal;Gigli, Marta;Stolfo, Davide;Zecchin, Massimo;De Luca, Antonio;Mestroni, Luisa;Sinagra, Gianfranco
2022

Abstract

with management options that importantly alter clinical course. In this context, many efforts have been made to identify risk factors and improve the accuracy of patient selection for device therapy and prevention of SCD. Although the wellknown mathematical models and stated criteria could provide a solid basis for arrhythmic risk stratification, at present patient risk assessment is moving in the direction of a periodic multiparametric evaluation on an individual basis, which cannot prescind from CMR and genetic information.
Pubblicato
https://www.sciencedirect.com/science/article/abs/pii/S1551713621000805
File in questo prodotto:
File Dimensione Formato  
pdf.pdf

non disponibili

Tipologia: Documento in Versione Editoriale
Licenza: Copyright Editore
Dimensione 7.27 MB
Formato Adobe PDF
7.27 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11368/3026927
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? 0
social impact